MiMedx Group, Inc.

MDXG· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$4.27+3.39%

2026-08-03

Financials

Valuation Metrics

MiMedx Group, Inc.'s Market Cap is $636M. At end of 2025 it was $1.00B. Ranked #2703 of 3,112 in US market (top 87%), #1154 of 1,445 on NASDAQ (top 80%), #213 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 79%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$636M	US#2,703/3,112 Sec#213/269
Revenue	$355M	US#2,480/3,112 Sec#93/269
Net Income	$6M	US#2,176/3,112 Sec#73/269
Total Assets	$281M	US#2,918/3,112 Sec#221/269
Net Assets	$216M	US#2,713/3,112 Sec#193/269
Value
P/E	101.97x	US#2,055/3,112 Sec#65/269
P/B	2.94x	US#1,651/3,112 Sec#85/269
P/S	1.79x	US#1,138/3,112 Sec#25/269
EV/EBITDA	22.63x	US#1,965/3,112 Sec#61/269
FCF Yield	6.58%	US#963/3,112 Sec#38/269
Profitability
ROE	2.89%	US#1,992/3,112 Sec#70/269
ROA	2.22%	US#1,561/3,112 Sec#65/269
Op. Margin	2.46%	US#2,277/3,112 Sec#78/269
Revenue Growth	-34.73%	US#2,843/3,112 Sec#157/269
Earnings Growth	-254.29%	US#2,259/3,112 Sec#84/269
Financial Health
Debt Ratio	30.09%	US#335/3,112 Sec#106/269
Total Debt	$2M	US#2,915/3,112 Sec#238/269
FCF	$42M	US#1,987/3,112 Sec#72/269
Cash	$136M	US#2,005/3,112 Sec#152/269
Current Ratio	5.33x	US#445/3,112 Sec#139/269
Net Debt/EBITDA	-6.06x	US#55/3,112 Sec#1/269
Performance
1Y Return	-40.36%	US#2,884/3,112 Sec#237/269
1M Return	8.10%	US#663/3,112 Sec#29/269
From 52W High	-46.42%	US#2,708/3,112 Sec#210/269
1Y MDD	-61.18%	US#2,754/3,112 Sec#217/269
Trading
Volume	1,827,652 shares	US#966/3,112 Sec#88/269
Trading Value	$8M	US#2,467/3,112 Sec#199/269
Per Share
EPS	$0.33	US#1,919/3,112 Sec#64/269
BPS	$1.74	US#2,540/3,112 Sec#183/269